Versant Venture Management, LLC Portfolio Holdings

Versant Venture Management, LLC has filed its 13F form on November 08, 2024 for Q3 2024 where it was disclosed a total value porftolio of $38.2 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Crispr Therapeutics Ag with a value of $23.4M, Repare Therapeutics Inc. with a value of $9.1M, Adverum Biotechnologies, Inc. with a value of $3.56M, Gritstone Bio, Inc. with a value of $2.07M, and Contineum Therapeutics, Inc. with a value of $0.

Examining the 13F form we can see an decrease of $6.88M in the current position value, from $45M to 38.2M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.